GRI Bio, Inc.
USD2.01
+0.00 (+0.50%)
CEO
W. Marc Hertz
IPO Date
2023-04-24
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.02
Prev. Close
$2.01
Day Low
$1.99
Day High
$2.10
52W Low
$1.97
52W High
$80.36
Market Cap
$0.00B
Volume
0.04M
| 39,897 |
| $1.93 |
| 22 Sept 2025 | Baker David Charles | director | A-Award | Acquired | 23,605 | $1.93 |
| 22 Sept 2025 | SIMPSON CAMILLA V | director | A-Award | Acquired | 23,605 | $1.93 |
| 22 Sept 2025 | Chaturvedi Vipin | Chief Scientific Officer | A-Award | Acquired | 43,222 | $1.93 |
| 22 Sept 2025 | Rongen Roelof | director | A-Award | Acquired | 23,605 | $1.93 |
| 22 Sept 2025 | Hertz Walter Marc | director, officer: Chief Executive Officer | A-Award | Acquired | 103,067 | $1.93 |
| 27 Aug 2025 | Hertz Walter Marc | director, officer: Chief Executive Officer | A-Award | Acquired | 26,688 | $1.41 |
| 27 Aug 2025 | Szekeres David Leslie | director | A-Award | Acquired | 10,276 | $1.41 |
| 27 Aug 2025 | Baker David Charles | director | A-Award | Acquired | 5,994 | $1.41 |